Skip to content

⚠️Technical Advisory: April 2027 Conformance Lead-Time Active

Institutional Disclosure: Partner commissions may apply.

Document ID: CP-TOS-2027-V2Jurisdiction: Texas, USA

Service Boundary &
Limitation of Liability

01. Technical Evaluation Only; No Legal Advice

CP.Labs and Dr. Charles Puryear operate strictly as objective technical evaluators and systems architects. We provide technical risk mitigation, architectural remediation, and WCAG 2.1 AA systems mapping. CP.Labs is a technical consultancy, not a law firm, and does not provide legal advice or legal services of any kind.

No deliverable, report, recommendation, or communication from CP.Labs shall be construed as legal advice, a legal opinion, or a determination of legal conformance or non-conformance with the Americans with Disabilities Act, the European Accessibility Act, the Disability Discrimination Act, or any other statute or regulation. Infrastructure hardening and technical remediation represent technical risk mitigation only and do not constitute a legal certification of regulatory conformance. Recipients requiring legal advice regarding accessibility obligations should consult licensed legal counsel.

02. Pre-Diagnostic Contracting

No formal architectural evaluations (Phase I) or engineering executions (Phase II) will commence without the explicit digital authorization of this Pre-Diagnostic Service Agreement. The Click-Wrap gateway utilized during the intake protocol establishes a legally binding Limitation of Liability shield prior to any systems intervention.

03. Economic Objectivity & Routing

To ensure clinical independence, CP.Labs monetizes via a dual-engine model. When technical evaluations identify that a custom architectural build presents unnecessary overhead, CP.Labs systematically advises migration to integrated SaaS platforms (e.g., Kajabi, Skool). These Track A migrations utilize strategic B2B affiliate partnerships. Track B entails high-ticket systems consulting for enterprise ecosystems. Transparent affiliate partnerships do not compromise clinical objectivity.

04. ABSOLUTE LIMITATION OF LIABILITY

Limitation of Liability.IN NO EVENT SHALL CP.LABS, ITS PRINCIPALS, EMPLOYEES, OR AGENTS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING BUT NOT LIMITED TO ATTORNEYS' FEES, SETTLEMENT COSTS, REGULATORY FINES, OR PENALTIES, ARISING OUT OF OR RELATED TO: (A) ANY THIRD-PARTY CLAIM, DEMAND, OR LITIGATION CONCERNING THE ACCESSIBILITY OR TECHNICAL CHARACTERISTICS OF THE RECIPIENT'S DIGITAL INFRASTRUCTURE; OR (B) ANY REGULATORY INVESTIGATION OR ENFORCEMENT ACTION RELATING TO THE RECIPIENT'S DIGITAL ECOSYSTEM.

CP.LABS TOTAL CUMULATIVE LIABILITY TO RECIPIENT FOR ANY CLAIM ARISING OUT OF OR RELATED TO SERVICES PROVIDED SHALL NOT EXCEED THE TOTAL FEES PAID BY RECIPIENT TO CP.LABS FOR THE SPECIFIC ENGAGEMENT GIVING RISE TO THE CLAIM. THE RECIPIENT ACKNOWLEDGES THAT CP.LABS DELIVERS TECHNICAL EVALUATION SERVICES ONLY, THAT THE RECIPIENT IS SOLELY RESPONSIBLE FOR ALL DECISIONS REGARDING THE DEPLOYMENT AND MAINTENANCE OF ITS DIGITAL INFRASTRUCTURE, AND THAT CP.LABS HAS NOT RENDERED AND SHALL NOT BE DEEMED TO HAVE RENDERED LEGAL ADVICE IN CONNECTION WITH ANY DELIVERABLE. THIS LIMITATION APPLIES TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW.


Mandatory Protocol

Initialize Phase I Diagnostic

Handshake initialization via digital authorization required.

Phase I Systems Review

$750.00

Clinical evaluation for Technical Risk Mitigation.

© 2026 CP.Labs Institutional Research • Clinical Technical Evaluation